Sensitivity of fecal immunochemical test for colorectal cancer detection differs according to stage and location

Background & Aims - Fecal immunochemical tests (FITs) are widely used for colorectal cancer (CRC) screening. FITs detect most CRCs. Although detection of CRC at early stages is most relevant for reducing CRC mortality, there is limited evidence for the stage-specific sensitivity of the FIT in CR...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Niedermaier, Tobias (VerfasserIn) , Tikk, Kaja (VerfasserIn) , Gies, Anton (VerfasserIn) , Bieck, Stefanie (VerfasserIn) , Brenner, Hermann (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 25 January 2020
In: Clinical gastroenterology and hepatology
Year: 2020, Jahrgang: 18, Heft: 13, Pages: 2920-2928
ISSN:1542-7714
DOI:10.1016/j.cgh.2020.01.025
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.cgh.2020.01.025
Verlag, lizenzpflichtig, Volltext: http://www.sciencedirect.com/science/article/pii/S154235652030104X
Volltext
Verfasserangaben:Tobias Niedermaier, Kaja Tikk, Anton Gies, Stefanie Bieck, Hermann Brenner

MARC

LEADER 00000caa a2200000 c 4500
001 1743359446
003 DE-627
005 20220819061340.0
007 cr uuu---uuuuu
008 201221s2020 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.cgh.2020.01.025  |2 doi 
035 |a (DE-627)1743359446 
035 |a (DE-599)KXP1743359446 
035 |a (OCoLC)1341384094 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Niedermaier, Tobias  |e VerfasserIn  |0 (DE-588)1141256126  |0 (DE-627)899005861  |0 (DE-576)470310774  |4 aut 
245 1 0 |a Sensitivity of fecal immunochemical test for colorectal cancer detection differs according to stage and location  |c Tobias Niedermaier, Kaja Tikk, Anton Gies, Stefanie Bieck, Hermann Brenner 
264 1 |c 25 January 2020 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 21.12.2020 
520 |a Background & Aims - Fecal immunochemical tests (FITs) are widely used for colorectal cancer (CRC) screening. FITs detect most CRCs. Although detection of CRC at early stages is most relevant for reducing CRC mortality, there is limited evidence for the stage-specific sensitivity of the FIT in CRC detection. We estimated stage- and location-specific sensitivities of a quantitative FIT in a large cohort of patients with CRC. - Methods - Fecal samples were collected before treatment from 435 patients with newly diagnosed CRC. Sensitivities of a quantitative FIT (FOB Gold, Sentinel Diagnostics; Milano, Italy) for tumors of different T stages and overall TNM stages (according to Union for International Cancer Control) were calculated at the cutoff recommended by the manufacturer (17 μg/g feces) and at alternative cutoffs, ranging from 10 to 40 μg/g feces, overall and stratified by tumor location. - Results - At the cutoff recommended by the manufacturer, the FIT detected T1 tumors with 52% sensitivity (95% CI, 37%-67%), T2 tumors with 79% sensitivity (95% CI, 68%-88%), T3 tumors with 93% sensitivity (95% CI, 89%-95%), and T4 tumors with 84% sensitivity (95% CI, 72%-92%) (Ptrend < .0001). The FIT detected stage I cancers with 68% sensitivity (95% CI, 57%-78%), stage II cancers with 92% sensitivity (95% CI, 87%-96%), stage III cancers with 82% sensitivity (95% CI, 73%-89%), and stage IV cancers with 89% sensitivity (95% CI, 80%-95%) (Ptrend 0.01). The FIT detected T1 colorectal tumors with sensitivity values that were 22%-52% lower than for tumors of other T stages and stage I CRC with sensitivity values that were 11%-33% lower than for later-stage CRCs, at any of the evaluated cutoff values. The FIT detected T1 and stage I CRCs in the distal colon with sensitivity values of 32% and 52%, respectively. - Conclusions - Although the FIT identifies patients with CRC with overall high sensitivity, it can miss approximately one-third of stage I CRCs. Studies are needed to increase noninvasive detection of early-stage CRC. 
650 4 |a Accuracy 
650 4 |a Site 
650 4 |a T Stage 
650 4 |a uicc Stage 
700 1 |a Tikk, Kaja  |e VerfasserIn  |0 (DE-588)1163755702  |0 (DE-627)1028118007  |0 (DE-576)508199549  |4 aut 
700 1 |a Gies, Anton  |d 1987-  |e VerfasserIn  |0 (DE-588)1151332208  |0 (DE-627)101156713X  |0 (DE-576)49759837X  |4 aut 
700 1 |a Bieck, Stefanie  |e VerfasserIn  |4 aut 
700 1 |a Brenner, Hermann  |e VerfasserIn  |0 (DE-588)1020516445  |0 (DE-627)691247005  |0 (DE-576)360642136  |4 aut 
773 0 8 |i Enthalten in  |t Clinical gastroenterology and hepatology  |d New York, NY : Elsevier Science, 2003  |g 18(2020,13) Artikel-Nummer e6, 18 Seiten  |h Online-Ressource  |w (DE-627)363139893  |w (DE-600)2102638-5  |w (DE-576)339260823  |x 1542-7714  |7 nnas  |a Sensitivity of fecal immunochemical test for colorectal cancer detection differs according to stage and location 
773 1 8 |g volume:18  |g year:2020  |g number:13  |g pages:2920-2928  |g extent:9  |a Sensitivity of fecal immunochemical test for colorectal cancer detection differs according to stage and location 
856 4 0 |u https://doi.org/10.1016/j.cgh.2020.01.025  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u http://www.sciencedirect.com/science/article/pii/S154235652030104X  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20201221 
993 |a Article 
994 |a 2020 
998 |g 1020516445  |a Brenner, Hermann  |m 1020516445:Brenner, Hermann  |d 850000  |d 851600  |d 50000  |e 850000PB1020516445  |e 851600PB1020516445  |e 50000PB1020516445  |k 0/850000/  |k 1/850000/851600/  |k 0/50000/  |p 5  |y j 
998 |g 1151332208  |a Gies, Anton  |m 1151332208:Gies, Anton  |d 50000  |e 50000PG1151332208  |k 0/50000/  |p 3 
998 |g 1163755702  |a Tikk, Kaja  |m 1163755702:Tikk, Kaja  |d 50000  |e 50000PT1163755702  |k 0/50000/  |p 2 
998 |g 1141256126  |a Niedermaier, Tobias  |m 1141256126:Niedermaier, Tobias  |d 50000  |e 50000PN1141256126  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN1743359446  |e 3827903467 
BIB |a Y 
SER |a journal 
JSO |a {"origin":[{"dateIssuedKey":"2020","dateIssuedDisp":"25 January 2020"}],"id":{"eki":["1743359446"],"doi":["10.1016/j.cgh.2020.01.025"]},"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"title":[{"title":"Sensitivity of fecal immunochemical test for colorectal cancer detection differs according to stage and location","title_sort":"Sensitivity of fecal immunochemical test for colorectal cancer detection differs according to stage and location"}],"person":[{"family":"Niedermaier","display":"Niedermaier, Tobias","given":"Tobias","role":"aut"},{"role":"aut","display":"Tikk, Kaja","family":"Tikk","given":"Kaja"},{"role":"aut","given":"Anton","family":"Gies","display":"Gies, Anton"},{"display":"Bieck, Stefanie","family":"Bieck","given":"Stefanie","role":"aut"},{"role":"aut","display":"Brenner, Hermann","family":"Brenner","given":"Hermann"}],"physDesc":[{"extent":"9 S."}],"relHost":[{"part":{"text":"18(2020,13) Artikel-Nummer e6, 18 Seiten","pages":"2920-2928","volume":"18","issue":"13","extent":"9","year":"2020"},"title":[{"title_sort":"Clinical gastroenterology and hepatology","subtitle":"the official clinical practice journal of the American Gastroenterological Association","title":"Clinical gastroenterology and hepatology"}],"physDesc":[{"extent":"Online-Ressource"}],"id":{"issn":["1542-7714"],"zdb":["2102638-5"],"eki":["363139893"]},"language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"origin":[{"dateIssuedDisp":"2003-","publisherPlace":"New York, NY","publisher":"Elsevier Science","dateIssuedKey":"2003"}],"pubHistory":["1.2003 -"],"note":["Gesehen am 01.03.11"],"recId":"363139893","disp":"Sensitivity of fecal immunochemical test for colorectal cancer detection differs according to stage and locationClinical gastroenterology and hepatology"}],"name":{"displayForm":["Tobias Niedermaier, Kaja Tikk, Anton Gies, Stefanie Bieck, Hermann Brenner"]},"note":["Gesehen am 21.12.2020"],"recId":"1743359446"} 
SRT |a NIEDERMAIESENSITIVIT2520